Interleukin-27 as a negative regulator of human neutrophil function

Area of Science:

• Immunology
• Cytokine Biology
• Innate Immunity

Background:

• Interleukin-27 (IL-27) is a cytokine with known immune regulatory properties.
• IL-27 is being explored as a therapeutic for immune diseases and cancers.
• The specific effects of IL-27 on human neutrophils remain largely uncharacterized.

Purpose of the Study:

• To investigate the impact of IL-27 on key human neutrophil functions.
• To determine if IL-27 receptor components are expressed on neutrophils.
• To elucidate IL-27's role in innate immune responses mediated by neutrophils.

Main Methods:

• Assessed IL-27 receptor (WSX-1/TCCR and gp130) expression on human neutrophils.
• Utilized in vitro assays to measure neutrophil adhesion, ROS production, and cytotoxic granule release.
• Quantified inflammatory cytokine production (IL-1β, TNF-α), MHC molecule expression, and neutrophil survival under IL-27 treatment.

Main Results:

• IL-27 receptor complex is constitutively expressed on human neutrophils.
• IL-27 suppressed neutrophil adhesion, ROS production, and cytotoxic granule release.
• IL-27 enhanced IL-1β production but not TNF-α, and did not affect MHC expression or neutrophil survival.

Conclusions:

• IL-27 predominantly down-modulates human neutrophil functions.
• These findings enhance the understanding of IL-27's role in innate immunity.
• IL-27's effects on neutrophils provide a basis for its potential therapeutic use.